These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19671847)

  • 1. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
    Girard N; Ostrovnaya I; Lau C; Park B; Ladanyi M; Finley D; Deshpande C; Rusch V; Orlow I; Travis WD; Pao W; Begg CB
    Clin Cancer Res; 2009 Aug; 15(16):5184-90. PubMed ID: 19671847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
    Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
    Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
    Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
    Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonality analysis of pulmonary tumors by genome-wide copy number profiling.
    Vincenten JPL; van Essen HF; Lissenberg-Witte BI; Bulkmans NWJ; Krijgsman O; Sie D; Eijk PP; Smit EF; Ylstra B; Thunnissen E
    PLoS One; 2019; 14(10):e0223827. PubMed ID: 31618260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods.
    Zhang Y; Hu H; Wang R; Ye T; Pan Y; Wang L; Zhang Y; Li H; Li Y; Shen L; Yu Y; Sun Y; Chen H; Garfield D
    Ann Surg Oncol; 2014 Dec; 21(13):4369-74. PubMed ID: 25081337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Takahashi Y; Shien K; Tomida S; Oda S; Matsubara T; Sato H; Suzawa K; Kurihara E; Ogoshi Y; Namba K; Yoshioka T; Torigoe H; Yamamoto H; Soh J; Toyooka S
    Cancer Sci; 2018 Nov; 109(11):3634-3642. PubMed ID: 30216592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.
    Girard N; Deshpande C; Azzoli CG; Rusch VW; Travis WD; Ladanyi M; Pao W
    Chest; 2010 Jan; 137(1):46-52. PubMed ID: 19376842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.
    Bao L; Messer K; Schwab R; Harismendy O; Pu M; Crain B; Yost S; Frazer KA; Rana B; Hasteh F; Wallace A; Parker BA
    PLoS One; 2015; 10(11):e0142487. PubMed ID: 26554380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
    Vignot S; Frampton GM; Soria JC; Yelensky R; Commo F; Brambilla C; Palmer G; Moro-Sibilot D; Ross JS; Cronin MT; André F; Stephens PJ; Lazar V; Miller VA; Brambilla E
    J Clin Oncol; 2013 Jun; 31(17):2167-72. PubMed ID: 23630207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
    Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
    Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
    Buys TP; Aviel-Ronen S; Waddell TK; Lam WL; Tsao MS
    J Thorac Oncol; 2009 Feb; 4(2):227-39. PubMed ID: 19179901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.
    Sun W; Feng L; Yang X; Li L; Liu Y; Lv N; Lin D
    Hum Pathol; 2018 Nov; 81():261-271. PubMed ID: 30420048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular analysis of synchronous double lung cancers.
    Arai J; Tsuchiya T; Oikawa M; Mochinaga K; Hayashi T; Yoshiura K; Tsukamoto K; Yamasaki N; Matsumoto K; Miyazaki T; Nagayasu T
    Lung Cancer; 2012 Aug; 77(2):281-7. PubMed ID: 22560922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma.
    van Rens MT; Eijken EJ; Elbers JR; Lammers JW; Tilanus MG; Slootweg PJ
    Cancer; 2002 Jan; 94(1):188-96. PubMed ID: 11815976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for common clonal origin of multifocal lung cancers.
    Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
    J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.
    Harms KL; Lazo de la Vega L; Hovelson DH; Rahrig S; Cani AK; Liu CJ; Fullen DR; Wang M; Andea AA; Bichakjian CK; Johnson TM; Tomlins SA; Harms PW
    JAMA Dermatol; 2017 Jun; 153(6):505-512. PubMed ID: 28403382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal origin of multiple lung cancers: K-ras and p53 mutations determined by nonradioisotopic single-strand conformation polymorphism analysis.
    Lau DH; Yang B; Hu R; Benfield JR
    Diagn Mol Pathol; 1997 Aug; 6(4):179-84. PubMed ID: 9360838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.
    Zhang B; Niu X; Zhang Q; Wang C; Liu B; Yue D; Li C; Giaccone G; Li S; Gao L; Zhang H; Wang J; Yang H; Wu R; Ni P; Wang C; Ye M; Liu W
    Lung Cancer; 2019 Aug; 134():108-116. PubMed ID: 31319968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.